RS22059
Pros and Cons of Allowing the Federal Government to Negotiate Prescription Drug Prices
February 18, 2005

Download Locations:

	Thurgood Marshall Law Library/University of Maryland School of Law
	University of North Texas Libraries

Summary:

The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) expressly forbids the Secretary of Health and Human Services (HHS) from negotiating the price of prescription drugs on behalf of Medicare beneficiaries. This report outlines the arguments for and against allowing the federal government to negotiate prescription drug prices on behalf of Medicare beneficiaries. This report will be updated, as needed.